Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Equity Ratio (2021 - 2026)

Envoy Medical's Equity Ratio history spans 6 years, with the latest figure at 0.34 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 114.61% to 0.34 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.34, a 114.61% increase, with the full-year FY2025 number at 1.42, up 13.01% from a year prior.
  • Equity Ratio hit 0.34 in Q1 2026 for Envoy Medical, up from 1.42 in the prior quarter.
  • Over the last five years, Equity Ratio for COCH hit a ceiling of 0.34 in Q1 2026 and a floor of 14.16 in Q4 2022.
  • Historically, Equity Ratio has averaged 1.77 across 5 years, with a median of 1.0 in 2023.
  • Biggest five-year swings in Equity Ratio: plummeted 13345.94% in 2022 and later surged 477.81% in 2023.
  • Tracing COCH's Equity Ratio over 5 years: stood at 14.16 in 2022, then soared by 98.48% to 0.21 in 2023, then plummeted by 660.52% to 1.63 in 2024, then rose by 13.01% to 1.42 in 2025, then soared by 123.98% to 0.34 in 2026.
  • Business Quant data shows Equity Ratio for COCH at 0.34 in Q1 2026, 1.42 in Q4 2025, and 0.94 in Q3 2025.